Figure 1
Bioprosthetic valve dysfunction and Bioprosthetic valve failure. BMI, body mass index; BVD, bioprosthetic valve dysfunction; BVF, bioprosthetic valve failure; HALT, hypo-attenuated leaflet thickening; RLM, reduced leaflet motion (from VARC-3 WRITING COMMITTEE: Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. See pages 1825–1857).

Bioprosthetic valve dysfunction and Bioprosthetic valve failure. BMI, body mass index; BVD, bioprosthetic valve dysfunction; BVF, bioprosthetic valve failure; HALT, hypo-attenuated leaflet thickening; RLM, reduced leaflet motion (from VARC-3 WRITING COMMITTEE: Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. See pages 1825–1857).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close